Modulation of cholesteryl ester transfer protein (CETP) activity |
| The invention claimed is: 1. A method for treating or preventing atherosclerosis in a human or ... |
|
Nucleic acids, vectors and host cells encoding heregulin |
| In accordance with the objects of this invention, we have identified and isolated novel ligand ... |
|
Immunoreactive peptides from Epstein-Barr virus |
| What is claimed is: 1. A polypeptide consisting of an amino acid sequence having the formula: (.phi.... |
|
DNA encoding stationary phase, stress response sigma factor from Mycobacterium tuberculosis |
| OF THE INVENTION It is a discovery of the present invention that entry of M. tuberculosis into a ... |
|
Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
| The present invention provides, among other things, a method of removing virus from a sample. The ... |
|
.alpha.-.beta. C4BP-type recombinant heteromultimeric proteins |
| The object of the present invention is therefore to develop recombinant soluble heteromultimeric ... |
|
Semi-refined carrageenan |
| The present invention provides methods for preparing a carrageenan product comprising the steps of ... |
|
Method for improving genetic stability of foreign insert nucleotide sequence in recombinant poliovirus |
| To be free from shortcomings of the poliovirus vector systems, in particular, genetic instability ... |
|
Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| The invention relates to adult dedifferentiated programmable stem cells derived from human ... |
|
Peptides which enhance transport across tissues and methods of identifying and using the same |
| The invention provides a method of identifying a peptide which permits or facilitates the transport ... |
|
|
Isolated nucleic acid encoding seven transmembrane receptors
| Details |
Inventors: Godiska, Ronald; Gray, Patrick W.; Schweickart, Vicki Louise;
Assignee: ICOS Corporation (Bothell, WA)
Primary Examiner: Ulm; John
Assistant Examiner:
Attorney, Agent or Firm: Marshall, O'Toole, Gerstein, Murray & Borun
DNA sequences encoding seven novel seven transmembrane receptors and variants thereof are disclosed as well as materials and methods for production of the same by recombinant techniques. Antibody substances specific for each of the seven transmembrane receptors are disclosed as useful for the modulation of the ligand/receptor binding reactions of the receptors. |
|
DETAILED DESCRIPTION The present invention is illustrated by the following examples relating to the isolation of human genomic and cDNA sequences encoding the novel 7TM receptors herein designated V28, V31, V112, R20, R2, R12 and RM3. More particularly, Example 1 describes the isolation of PCR fragments encoding portions of the R20, V31, V28 and V112 7TM receptors. Example 2 describes the isolation of a full length human V31 genomic clone. Example 3 describes the isolation of a V31 human cDNA clone and further characterization of the V31 genomic clone. Example 4 presents experiments which reveal the chromosomal location of the human V31 gene. Example 5 describes the cloning of a full length murine V31 genomic clone. The cloning of a full length, human genomic clones for V28 is described in Example 6. Example 7 describes the isolation of a full length human V28 cDNA. Example 8 sets out a description of a full length human V112 cDNA. Example 9 describes the isolation of a full length genomic DNA encoding human R20. The isolation of full length R2 and R12 7TM receptor genes from a human genomic fetal liver library is detailed in Example 10. Example 11 describes the cloning of a cDNA encoding the RM3 7TM receptor. Example 12 presents a comparison of the amino acid sequences of 7TM receptors of the invention with amino acid sequences of previously described 7TM receptors. The transfection of human cells with genomic and cDNA sequences encoding the 7TM receptor V31 and the phenotype of the transfected cells are detailed in Example 13. Expression of 7TM receptors of invention in various human tissues and hematopoietic cell lines as assayed by Northern blot and in situ hybridization is described in Example 14. Examples 15 and 16 respectively describe the expression of V31 and R20 genomic sequences as fusion proteins with Glutathione-S-Transferase in E. coli, while Example 17 describes the expression of V31 and V28 cDNA sequences as fusion proteins with Glutathione-S-Transferase in E. coli. Example 18 describes the generation of polyclonal sera reactive with the V31 fusion proteins and V31 peptides useful for generating monoclonal and polyclonal antibodies specific for V31
|
| Related patents |
|
|
TIE-2 ligands, methods of making and uses thereof
What is claimed is: 1. An isolated antibody which specifically binds a ligand wherein the ligand consists of the amino acid sequence of SEQ ID NO: 2. 2. The antibody of ...
|
|
|
Phthalidyl-isoquinoline derivatives
We claim: 1. A compound of the formula ##STR6## wherein each of R.sub.1, R.sub.2, R.sub.4, R.sub.5 and R.sub.6 is lower alkoxy; R.sub.3 is hydrogen or lower alkoxy; and R...
|
|
|
Immune suppressive product
What is claimed is: 1. An oral vaccine, wherein said vaccine comprises a composition wherein said composition comprises a non-antibody fraction of milk and wherein said ...
|
|
|
Anti-allergy anti-inflammatory composition
OF THE INVENTION The following unique features of Nimesulide may prove to be quite beneficial in all allergic disorders. 1) Nimesulide is a potent stabilizer of mast ...
|
|
|
Dermatophagoides nucleic acid molecules, proteins and uses thereof
OF THE INVENTION The present invention provides for isolated proteins having molecular weights ranging from about 60 kilodaltons (kD) to about 109 kD, that include at ...
|
|
|
Stabilized primate lentivirus envelope glycoproteins
OF THE INVENTION We have discovered a series of novel polypeptides that can (1) enhance the immunogenicity of primate lentivirus envelope proteins for certain conserved ...
|
|
|
Endothelial-monocyte activating polypeptide III antibodies
What is claimed is: 1. An isolated antibody or fragment thereof that specifically binds to a protein whose amino acid sequence consists of amino acid residues 1 to 168 ...
|
|
|
Bacillus thuringiensis toxins active against scarab pests
We claim: 1. An isolated polynucleotid encoding a toxin which is active against scarab pests, said polynucleotide encoding the amino acid sequence of SEQ ID NO. 4 or a ...
|
|
|
Growth differentiation factor-8 transgenic mice
The present invention provides a cell growth and differentiation factor, GDF-8, a polynucleotide sequence which encodes the factor, and antibodies which are ...
|
|
|
Method for using phagocytic particles and ATP receptors to deliver antigens to MHC class I receptors to induce immunity against microbial pathogens or tumors or to suppress immunity
OF THE INVENTION This invention provides a method of delivering an antigen to an Class I MHC receptor to induce immunity against the antigen in a subject having a ...
|
|
|